Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mallal

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|April 18, 1998
Highly active antiretroviral therapyM French, N Lenzo, M John, et al.
Lancet (London, England)|June 30, 1990
MHC genes and HIV infectionS Mallal, P U Cameron, M A French, et al.
Clinical Endocrinology|June 21, 2011
Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIVE Hammond, E McKinnon, P Glendenning, et al.
QJM : Monthly Journal of the Association of Physicians|October 21, 2003
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?D Nolan, G F Watts, S E Herrmann, et al.
AIDS (London, England)|June 27, 2001
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavirD Nolan, R Upton, E McKinnon, et al.
Immunological Reviews|May 13, 1999
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseasesP Price, C Witt, R Allcock, et al.
HIV Medicine|July 16, 2003
HIV lipodystrophy: prevalence, severity and correlates of risk in AustraliaJ Miller, A Carr, S Emery, et al.
Gene|September 14, 2010
Reducing chimera formation during PCR amplification to ensure accurate genotypingR P Smyth, T E Schlub, A Grimm, et al.
Internal Medicine Journal|October 6, 2007
Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of careS Herrmann, E McKinnon, M John, et al.
AIDS (London, England)|October 2, 2001
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre studyA Carr, J Hudson, J Chuah, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|April 18, 1998
Highly active antiretroviral therapyM French, N Lenzo, M John, et al.
Lancet (London, England)|June 30, 1990
MHC genes and HIV infectionS Mallal, P U Cameron, M A French, et al.
Clinical Endocrinology|June 21, 2011
Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIVE Hammond, E McKinnon, P Glendenning, et al.
QJM : Monthly Journal of the Association of Physicians|October 21, 2003
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?D Nolan, G F Watts, S E Herrmann, et al.
AIDS (London, England)|June 27, 2001
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavirD Nolan, R Upton, E McKinnon, et al.
Immunological Reviews|May 13, 1999
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseasesP Price, C Witt, R Allcock, et al.
HIV Medicine|July 16, 2003
HIV lipodystrophy: prevalence, severity and correlates of risk in AustraliaJ Miller, A Carr, S Emery, et al.
Gene|September 14, 2010
Reducing chimera formation during PCR amplification to ensure accurate genotypingR P Smyth, T E Schlub, A Grimm, et al.
Internal Medicine Journal|October 6, 2007
Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of careS Herrmann, E McKinnon, M John, et al.
AIDS (London, England)|October 2, 2001
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre studyA Carr, J Hudson, J Chuah, et al.
Pageof 3